AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating Challenges in the FDA Approval Process for Cancer Therapy
This chapter explores the FDA's accelerated approval of Adaptimmune's Teslera for metastatic synovial sarcoma, detailing Phase Two trial results and clinical challenges. It also addresses the socioeconomic factors influencing the trial, including the impact of the COVID pandemic and the historical treatment landscape for this rare disease.